Cell MedX Corp. Reports Officer Changes & Compensation
Ticker: STME · Form: 8-K · Filed: Feb 28, 2024 · CIK: 1493712
| Field | Detail |
|---|---|
| Company | Cell Medx Corp. (STME) |
| Form Type | 8-K |
| Filed Date | Feb 28, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, compensation
TL;DR
**Cell MedX Corp. just filed an 8-K about changes in their board/officers and executive pay.**
AI Summary
Cell MedX Corp. filed an 8-K on February 28, 2024, reporting events that occurred on February 27, 2024. The filing indicates information regarding the departure or election of directors or officers, as well as compensatory arrangements for certain officers. Additionally, the report includes details about financial statements and exhibits.
Why It Matters
This filing signals potential shifts in leadership and executive compensation at Cell MedX Corp., which could influence future strategic direction and financial performance.
Risk Assessment
Risk Level: medium — The filing provides administrative updates without inherently positive or negative financial implications.
Key Players & Entities
- Cell MedX Corp. (company) — registrant
- February 27, 2024 (date) — date of earliest event reported
- February 28, 2024 (date) — filing date
- 000-54500 (other) — Commission File Number
- NV (other) — State of incorporation
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is CELL MEDX CORP.
What was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported was February 27, 2024.
What items of information are included in this 8-K filing?
The 8-K includes information on 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' and 'Financial Statements and Exhibits'.
Where is Cell MedX Corp.'s business address located?
Cell MedX Corp.'s business address is 820 - 1130 Pender Street, West Vancouver, British Columbia V6E 4A4.
What is the Commission File Number for Cell MedX Corp.?
The Commission File Number for Cell MedX Corp. is 000-54500.
Filing Stats: 430 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-02-28 16:18:54
Filing Documents
- cmxc-20240227.htm (8-K) — 21KB
- cmxc_ex991.htm (EX-99.1) — 6KB
- cmxcex991_1.jpg (GRAPHIC) — 16KB
- 0001393905-24-000057.txt ( ) — 153KB
- cmxc-20240227_def.xml (EX-101.DEF) — 2KB
- cmxc-20240227_lab.xml (EX-101.LAB) — 12KB
- cmxc-20240227_pre.xml (EX-101.PRE) — 8KB
- cmxc-20240227.xsd (EX-101.SCH) — 2KB
- cmxc-20240227_htm.xml (XML) — 3KB
02 APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
ITEM 5.02 APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On February 27, 2024, Mr. Brad Hargreaves resigned from the Board of Directors of Cell MedX Corp. (the "Company"). The resignation of Mr. Hargreaves was not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practice or otherwise. A copy of the Company's news release regarding the resignation of Mr. Hargreaves is attached to this Form 8-K.
01 FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits The following exhibits are provided with this Current Report: Exhibit Number Description of Exhibit 99.1 News Release dated February 28, 2024. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELL MEDX CORP. Date: February 28, 2024 By: /s/ David Jeffs David Jeffs, Chief Executive Officer 3